Gabrielle's Angel Foundation For Cancer Research Welcomes Jho Low To Its Board Of Directors
NEW YORK, Jan. 29, 2015 /PRNewswire/ -- Gabrielle's Angel Foundation announced today that global investor and philanthropist Jho Low has joined the Foundation's Board of Directors. Low was honored at Angel Ball 2014 – the Foundation's annual fundraiser – in recognition of his significant humanitarian and philanthropic contributions in support of cancer research.
"Mr. Low has proven his tremendous commitment to cancer research through his charitable work, and we are honored to have him join our board," said Co-founder Denise Rich. "We look forward to working closely with him to fulfill our mission of funding more effective therapies for patients with leukemia, lymphoma and related cancers."
"Gabrielle's Angel Foundation is an essential organization in the fight against cancer, a disease that has affected so many of us and our families, including my own," said Jho Low, Chief Executive Officer of Jynwel Capital Limited and Director of Jynwel Charitable Foundation Limited. "Gabrielle's Angel Foundation has been a partner of Jynwel Charitable Foundation for the last two years, and I am excited to work even more closely with the team on an ongoing basis to help eradicate this deadly disease."
Low is a global investor and philanthropist who encourages market access and advances human progress through capital and social investments across a diverse range of projects. He is the co-founder and Chief Executive Officer for Jynwel Capital Limited, an international investment firm based in Hong Kong. Low oversees both the operations and investment strategy for the firm and cultivates lifelong partnerships with significant investors in Asia and the Middle East, such as leading sovereign wealth funds, major international investment companies and large family enterprises.
Low has led and invested in numerous mergers and acquisitions, restructurings and financings, cross-border transactions, leveraged buyouts, and other investment projects of various sizes and complexity across a variety of sectors, including media and entertainment, consumer and retail, energy and resources, real estate and hospitality, precious metals, commodities, and infrastructure.
Low is a director of Jynwel Charitable Foundation Limited ("the Foundation"), a charitable institution committed to funding breakthrough programs that scale and accelerate advancements in public health, environmental & wildlife conservation, and education in every corner of the world. The Foundation provides substantial, long-term grants towards global efforts at cancer and research, environmental & wildlife preservation, and education, building on the multi-generational legacy of the Low family's philanthropy.
Low has served on the board and as an advisor of a number of listed, private and sovereign wealth funded companies. Low is currently a member of the board of the Viceroy Hotel Group and The Electrum Group, and he is also an alternate director of Lilestone Limited ("Myla"). Additionally, Low is Non-executive Chairman, Asia, for EMI Music Publishing, also serving as a member of its advisory board. Through the Foundation, he is a member of The Anderson Assembly and the Board of Visitors of The University of Texas MD Anderson Cancer Center, and he serves on the Board of Directors of Panthera, the world's leading wild cat conservation organization. Low maintains an active role with National Geographic as a member of its International Council of Advisors and the Advisory Board of National Geographic's Pristine Seas project. Additionally, he has been selected as one of the founding Members of the Board of Directors of the new IRIN, the humanitarian news service; and is a member of The Trust, a distinguished society recognizing philanthropic leaders who support Children's National Health System in Washington, DC.
In 2014, Low received the International Entrepreneur of the Year Award from the Houston Asian Chamber of Commerce for his approach to sustainable investing and disruptive philanthropy.
Low graduated with a Bachelor of Science in Economics from The Wharton School of the University of Pennsylvania.
About Gabrielle's Angel Foundation for Cancer Research
Gabrielle's Angel Foundation funds the nation's best and brightest scientific investigators whose research focuses on finding less toxic treatments for patients with leukemia, lymphoma, and related cancers. Since its inception, Gabrielle's Angel Foundation has awarded $26 million in grants making it one of the largest non-governmental sources of grant support for blood cancer research in the nation. In 2012, the Foundation opened a sister chapter, Gabrielle's Angel Foundation UK, which provides support for blood cancer research at Great Britain's leading institutions. Help us on our quest: @CureCancerNow. For more information, please visit: gabriellesangels.org.
SOURCE Gabrielle's Angel Foundation for Cancer Research
Share this article